Continuous ambulatory peritoneal dialysis (CAPD) is now a standard therapeutic modality of end-stage renal disease (ESRD) (1). About 80% of ESRD patients in Hong Kong are treated by CAPD. Peritoneal dialysis (PD) related infections, notably peritonitis, are major complications leading to patient morbidity, mortality and technique failure. In this issue, we have two papers addressing these probl...

OBJECTIVE To investigate whether the presence of kidney stones increase the risk of end stage renal disease (ESRD) or other adverse renal outcomes. DESIGN A registry cohort study using validated algorithms based on claims and facility utilisation data. Median follow-up of 11 years. SETTING Alberta, Canada, between 1997 and 2009. PARTICIPANTS 3,089,194 adult patients without ESRD at baseli...

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease. After about ten years of evolution, it leads to a slow and progressive loss function eventually causing insufficiency failure. Few data exist on this pathology in Africa Chad. The objective study was analyze epidemiological, diagnostic therapeutic aspects ADPKD. Methodology: This multice...

As the US population continues to age, new cases of end-stage renal disease (ESRD) in individuals, aged 85 years or older (the oldest old), are increasing. Many patients who begin hemodialysis despite questionable benefit may struggle with high symptom burden and rapid functional decline. This article reviews the history regarding the funding and development of the Medicare ESRD program, review...

The world is facing an epidemic of chronic kidney disease (CKD) and in South Africa, death rates from end-stage renal disease (ESRD) have risen by 68% from 1999 to 2006.

Health care providers, patients, the end stage renal disease (ESRD) networks, and HCFA have developed the ESRD Health Care Quality Improvement Program (HCQIP) in an effort to assess and improve care provided to ESRD patients. Currently, the ESRD HCQIP focuses on collecting information on quality indicators (QIs) for treatment of anemia, delivery of adequate dialysis, nutritional status, and blo...

Diabetes Mellitus (DM) has become a modern day epidemic, affecting millions of people around the globe. It has grown parallel to the rising epidemic of obesity, leading to increased cardiovascular disease (CVD) morbidity and mortality. Currently, DM is the most common cause of chronic kidney disease (CKD) and subsequent end stage renal disease (ESRD) requiring renal replacement therapy. Althoug...

Medicaid is believed to serve as the major insurer for end stage renal disease (ESRD) patients who are ineligible for Medicare coverage. Demographics, receipt of dialysis services, and costs of Medicaid-only populations were compared with Medicare ESRD populations in California, Georgia, and Michigan. Notable differences in patient demographics, dialysis practice patterns, and inpatient health ...

There are different approaches to treat patients with End Stage Renal Disease (ESRD): hemodialysis, peritoneal dialysis, renal transplantation and conservative medical management. The choice of the best therapy for each patient, needs both clinical and ethical skills. The Ethics Committee of the Chilean Society of Nephrology has elaborated recommendations to help health workers to deal with the...

Cardiovascular disease is the leading cause of mortality and morbidity in patients with chronic kidney disease, which is partly explained by the fact that 40-70% of patients receiving dialysis have significant coronary artery disease. Recent clinical studies have shown that lower serum magnesium (Mg) levels are associated with vascular calcification and cardiovascular mortality among patients w...